High Performance Liquid Chromatography (HPLC) is an instrumental technique mainly used for the analysis of organic compounds that have high boiling points, are non‑volatile, thermally unstable, or have large molecular weights. It consists of several components: a solvent reservoir, pump, injector, chromatographic column, detector, and recorder. The mobile phase from the solvent reservoir is delivered into the system by a high‑pressure pump. The sample solution enters the mobile phase through the injector and is carried into the chromatographic column (the stationary phase). Because each component in the sample solution has a different partition coefficient between the two phases, as they move relative to each other they undergo repeated adsorption‑desorption partitioning processes. This creates significant differences in their migration speeds, causing them to be separated into individual components that elute from the column one after another. When they pass through the detector, the sample concentration is converted into an electrical signal that is transmitted to a recorder, and the data are printed as a chromatogram.
This article will review the evolution of HPLC, analyze current development trends, and look ahead to future directions, providing a reference for researchers and professionals in related industries.
I. The Evolution of HPLC Technology
High performance liquid chromatography originated from column chromatography in the 1940s, but the modern HPLC system as we know it was born in the late 1960s. The introduction of the first commercial HPLC instrument in 1966 marked a new era for analytical chemistry. In the 1970s, the emergence of high‑pressure pumps, efficient stationary phases, and sensitive detectors greatly improved separation efficiency, reducing analysis time from hours to minutes.
The 1980s and 1990s were a golden period for HPLC technology: automated control systems replaced manual operation, computer‑based data processing software became widespread, and column packing materials evolved from porous silica to monodisperse microspheres. These breakthroughs established HPLC as a standard analytical method in the pharmaceutical, environmental, and food industries.
II. Development Trends in HPLC Technology
In modern analytical laboratories, UHPLC has become a basic configuration and in some labs has even become the workhorse instrument. Sub‑2 µm packings combined with 1500 bar ultra‑high‑pressure systems increase analysis speed by a factor of 5–9 and more than triple the sensitivity. These numbers may not mean much, but the practical difference is enormous. For example, testing 20 tablet samples in a pharmaceutical quality control lab: a traditional HPLC method takes 4 hours, whereas UHPLC gets the job done in 2 hours, so you don’t have to rush to issue reports before the end of the day. Colleagues in environmental monitoring stations also say that during the flood season, when there are many water samples, using ordinary HPLC forces everyone to work overtime and still may not meet the deadline; with UHPLC, efficiency improves and the team can breathe easier. Manufacturers are still investing in R&D to improve UHPLC durability – for example, extending seal life under ultra‑high pressure and improving column‑oven temperature control accuracy. After all, for analysts, “fast” is good, but “stable and reliable” is what truly saves effort.
The “intelligence” of today’s HPLC is not a marketing gimmick; it truly helps solve real problems. Take automated method development: in the past, developing a new sample method meant manually testing mobile phase ratios, column temperature, and flow rate – sometimes ten or more attempts without achieving good peak separation, wasting time, effort, and reagents. Today’s intelligent HPLC systems can recommend initial conditions based on sample properties, then automatically iterate and optimise based on preliminary results, delivering a workable method in half a day – especially useful for impurity screening in new drug development. There is also intelligent fault diagnosis: previously, when the instrument alarmed, you had to go through the manual line by line to check whether it was a pump or a detector problem, sometimes wasting hours only to find a bubble in the injection valve. Now the system directly indicates “possible fault points” and even suggests solutions, such as “flush the injection valve” or “check whether the mobile phase has run out”. This allows even novices to handle issues quickly without constantly asking senior colleagues for help.
Hyphenation of HPLC with mass spectrometry (LC‑MS) or with NMR (LC‑NMR) is also very practical. In the past, isolating an unknown peak required re‑analysis with other instruments, a back‑and‑forth process. With LC‑MS, molecular structure information is obtained immediately after separation. Pharmaceutical companies doing impurity studies no longer have to repeatedly purify samples; in proteomics research, LC‑MS simultaneously provides peak shape and structural data, enabling efficient handling of complex samples. Last year I helped a friend with a metabolomics project – verifying unknown peaks used to take a week, but with LC‑MS we got results in less than two days. That is the benefit of hyphenation.
Today, “green” is no longer just a trend in the laboratory – it really saves money and reduces headaches. For example, microbore columns consume more than 50% less organic solvent than traditional 4.6 mm i.d. columns. In our lab, we run dozens of samples every day; over a year, the savings in solvent costs are considerable. Moreover, less organic waste means lower disposal costs and less pressure on the laboratory’s environmental compliance. Supercritical fluid chromatography (SFC) uses CO₂ as the primary mobile phase – it is environmentally friendly and can separate lipid‑soluble samples that are difficult for conventional HPLC. The CO₂ can be recovered, avoiding the emission concerns associated with organic solvents.
Biodegradable mobile phases are also very convenient. Phosphate buffers used to deposit in the detector over time, requiring regular disassembly and cleaning – a real nuisance. Switching to citrate buffer meets detection requirements and is biodegradable, so you no longer have to disassemble and clean the detector so often. These changes may seem small, but they reflect a real shift from “only caring about the result” to “balancing operational cost and environmental protection”, meeting the management needs of modern laboratories and making our work easier.
III. Cutting‑Edge Breakthroughs: New Research Progress and Application Expansion
Innovations in chromatographic columns are increasingly aligned with practical needs. For example, new core‑shell columns have a porous outer shell and a solid inner core. They offer separation efficiency comparable to sub‑2 µm packings but with 30% lower backpressure. They can be used with older HPLC systems without replacing the ultra‑high‑pressure pump – a great benefit for laboratories that do not want to upgrade equipment frequently.
Breakthroughs in chiral stationary phases have also been very helpful. In the past, separating chiral isomers for chiral drug analysis was extremely difficult; you had to repeatedly adjust mobile phase additives and sometimes use chiral derivatisation reagents, which involved many steps, was error‑prone, and gave poor reproducibility. New chiral stationary phases (e.g., cyclodextrin‑ or protein‑based) can directly separate many chiral compounds with good reproducibility, eliminating the worry that “it might separate this time but not next time”. Last month I helped a pharmaceutical company with chiral impurity testing; using a new chiral column succeeded in one run – previously it would have taken at least three or four attempts.
High‑temperature tolerant stationary phases have also expanded method development possibilities. Previously columns could only withstand up to 60 °C; for high‑boiling point samples the only option was to increase the mobile phase ratio, and the peak shape was not always good. New stationary phases can tolerate over 100 °C. Raising the column temperature speeds up separation and reduces organic solvent usage. For example, measuring antioxidants in oils used to require 80% acetonitrile in the mobile phase; now, by raising the column temperature to 80 °C, 60% acetonitrile gives better separation – greener and solvent‑saving, two benefits in one.
The application scope of HPLC is now much broader than when we first entered the field. Many areas that were “unthinkable” before can now be addressed with HPLC. Take mRNA vaccine analysis: the mRNA fragments in the vaccine vary in size, and purity control is critical. Previously there was no good method; now two‑dimensional liquid chromatography (2D‑LC) separates fragments of different sizes in the first dimension, and the second dimension further purifies and detects them, allowing precise identification of impurity fragments – extremely important for vaccine quality control.
Quality control of cell therapy products is also challenging. The residual protein and nucleic acid fragments in the product are present at very low levels and can be easily disturbed by cell debris, making accurate measurement difficult. Now, combining HPLC with immunoaffinity columns allows specific capture of the target substances, which are then detected with high‑sensitivity detectors – finally solving the problem of “inaccurate measurement of trace residues”. Characterisation of nanomedicines previously required several instruments to measure particle size distribution and encapsulation efficiency – cumbersome and error‑prone. Now, HPLC equipped with a light‑scattering detector measures both particle size and concentration in a single run, eliminating the need to transfer methods between instruments and saving a lot of trouble.
AI‑assisted HPLC is also attracting interest; it might enable single‑molecule‑level detection of single‑cell metabolites with extremely high resolution. But honestly, what we care about more is “can it be put into practice?” At present, this approach still requires a large amount of local laboratory data to train the model, and its generalisability needs improvement. Still, it shows us that HPLC can move toward greater precision and microscopic analysis. In the future, it might solve the problem of detecting very small samples such as clinical biopsy specimens – a very promising direction for those of us doing applied research.
